Idea principal
In 30 studies of wearable sensors in clinical and real-world settings, 67% (20/30) used inertial measurement units, and 4 studies (13%) reported high accuracy for fall risk and mobility decline (AUC up to 0.97). The studies were mostly observational, with varied sensor placement and methods, so the best-case accuracy may not hold in everyday use.
Study design
Revisión de evidencia
Reading basis
Published abstract
Reading focus
Design & applicability
Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.
Pregunta de investigación
Wearable motion sensors can track walking, mobility and function continuously, but sensor placement, data processing and real-world validation are not standardised. The authors reviewed how these devices are used to assess mobility, predict disease risk and support rehabilitation, and what limits them.
Población y método
Systematic review following PRISMA, searching PubMed, Scopus and Web of Science up to March 9, 2025, for studies using wearable sensors in clinical or real-world environments. A total of 30 studies were synthesised qualitatively. Extracted data included design, population, sensor type and placement, machine learning algorithms and clinical outcomes. The abstract does not report participant numbers or a quality appraisal.
Resultados
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Study designs were 43% (13/30) observational, 27% (8/30) experimental and 10% (3/30) randomised controlled trials.
- 2Inertial measurement unit sensors were used in 67% (20/30) of studies, most often worn on the wrist (13/20, 65%).
- 3Machine learning was common, led by random forest (6/30, 20%) and deep learning (5/30, 17%).
- 4Applications covered Parkinson disease, stroke, multiple sclerosis and frailty. Four studies (13%) reported high predictive accuracy for fall risk and mobility decline, with area under the receiver operating characteristic curve up to 0.97.
Límites e incertidumbre
- 1With only 30 studies, many observational and covering several conditions, the review cannot say how well any one sensor works for one condition.
- 2The 0.97 AUC is a best-case figure from 4 studies; the abstract does not say whether it was tested on separate data, so it may overstate real-world performance.
- 3The authors note that sensor placement, data analysis and machine learning pipelines are not standardised, which makes studies hard to compare.
- 4The abstract gives no quality appraisal or participant counts, and this reading is based on the abstract only.
Relevancia práctica
Motion sensors, including wrist devices, are being studied for monitoring gait, fall risk and rehabilitation progress, and early results look promising. The review does not show that a consumer watch can predict falls or diagnose a condition. Concerns about balance or falls should go to a clinician.
Tus datos
If your device reports walking speed, steps or gait steadiness, follow trends from the same device worn on the same wrist, since the review shows placement and processing differ across studies. A clear decline in mobility over weeks is worth discussing with a clinician, not treating as a diagnosis.
Cómo interpretar la evidencia
Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.
Resumen estructurado de los autores English
El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.
Background
Wearable sensor technologies such as inertial measurement units, smartwatches, and multisensor systems have emerged as valuable tools in clinical and real-world health monitoring. These devices enable continuous, noninvasive tracking of gait, mobility, and functional health across diverse populations. However, challenges remain in sensor placement standardization, data processing consistency, and real-world validation.
Objective
This systematic review aimed to evaluate recent literature on the clinical and research applications of wearable sensors. Specifically, it investigated how these technologies are used to assess mobility, predict disease risk, and support rehabilitation. It also identified limitations and proposed future research directions.
Methods
This review was conducted according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. We searched the PubMed, Scopus, and Web of Science databases up to March 9, 2025. Inclusion criteria focused on studies using wearable sensors in clinical or real-world environments. A total of 30 eligible studies were identified for qualitative synthesis. Data extracted included study design, population characteristics, sensor type and placement, machine learning algorithms, and clinical outcomes.
Results
Of the included studies, 43% (13/30) were observational, 27% (8/30) were experimental, and 10% (3/30) were randomized controlled trials. Inertial measurement unit-based sensors were used in 67% (20/30) of the studies, with wrist-worn devices being the most common (13/20, 65%). Machine learning techniques were frequently applied, with random forest (6/30, 20%) and deep learning (5/30, 17%) models predominating. Clinical applications spanned Parkinson disease, stroke, multiple sclerosis, and frailty, with several studies (4/30, 13%) reporting high predictive accuracy for fall risk and mobility decline (area under the receiver operating characteristic curve up to 0.97).
Conclusions
Wearable sensors show strong potential for mobility monitoring, disease risk assessment, and rehabilitation tracking in clinical and real-world settings. However, challenges remain in standardizing sensor protocols and data analysis. Future research should focus on large-scale, longitudinal studies; harmonized machine learning pipelines; and integration with cloud-based health systems to improve scalability and clinical translation.
Fuentes y atribución
Advancements in Wearable Sensor Technologies for Health Monitoring in Terms of Clinical Applications, Rehabilitation, and Disease Risk Assessment: Systematic Review.
Gu B, Kim HS, Kim H, Yoo JI.
JMIR mHealth and uHealth · 2026-01-09
DOI: 10.2196/76084 ↗PubMed · 41511829 ↗Europe PMC · Licencia registrada: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada
Fuentes verificadas 2026-11-01
Guías prácticas
Leer en contexto
Activity–stroke and heart attack curves differ by accelerometer processing method
Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.
Preventive Medicine
Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven
A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.
Forensic Science International
Activity trackers: about 1,800 more steps a day, but small effects on other outcomes
An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.
The Lancet Digital Health
Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages
In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.
Sleep

